Cannabinoids and Cerebellar-Motor Functioning

Conditions

Cannabis | Psychotic Disorders

Trial Phase

Trial Purpose and Description

Trial Purpose

The purpose of this study is to characterize the dose-related effects of delta-9-tetrahydrocannabinol (∆9-THC) in healthy individuals on cerebellum-dependent motor functions


Participation Guidelines

Age:
21 Years - 35 Years
Gender:
Both

Eligibility Criteria

Inclusion Criteria:

  • Must have used cannabis at least once in their lifetime
  • No cannabis use in the past month
  • Men and women aged 21 to 35 years (extremes included) on the day of the first dosing

Exclusion Criteria:

  • Hearing deficits
  • Psychiatric or mental disorders
  • Hearing Deficits
Sponsor:
National Institute on Drug Abuse
Dates:
12/14/2012
Last Updated:
Study HIC#:
1211011055